P1.04-32 Phase I/II Study of the A2AR Antagonist NIR178 (PBF-509), an Oral Immunotherapy, in Patients (pts) with Advanced NSCLC
JOURNAL OF THORACIC ONCOLOGY（2018）
关键词
Immunotherapy,adenosine 2A receptor,NIR178/PBF509
AI 理解论文
溯源树
样例
生成溯源树，研究论文发展脉络
Chat Paper
正在生成论文摘要